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OBJECTIVES: To estimate the prevalence of prefrailty,
frailty, comorbidity, and disability in the youngest old and
to identify chronic diseases associated with individual
frailty criteria.
DESIGN: Population-based cohort study of noninstitution-
alized elderly adults at baseline; cross-sectional analysis.
SETTING: Lausanne, Switzerland.
PARTICIPANTS: One thousand two hundred eighty-three
individuals with complete data on frailty, aged 65 to 70
(58.5% women).
MEASUREMENTS: Frailty was assessed according to an
adaptation of Fried’s criteria (shrinking, weakness, exhaus-
tion, slowness, and low activity, three criteria needed for
the diagnosis of frailty, 1 to 2 for prefrailty). Other out-
comes were diseases diagnosed by a doctor (2 chronic
diseases: comorbidity) and limitations in activities of daily
living (ADLs, basic and instrumental).
RESULTS: At baseline, of 1,283 participants 71.1% were
classified as nonfrail, 26.4% as prefrail, and 2.5% as frail.
The proportion of women increased across these three
groups (56.5%, 62.8%, and 71.9%, respectively; P = .01),
as did the proportion of individuals with one or more
chronic diseases (68.0%, 82.8%, and 90.6%, respectively;
P < .001) and the proportion with basic or instrumental
ADL disability (1.6%, 10.3%, and 59.4%, respectively;
P < .001). Weakness (low grip strength) was the most fre-
quent criterion (14.3%). Prefrail participants had signifi-
cantly more comorbidity and ADL disability than nonfrail
participants (P < .001). When present in isolation, weak-
ness was associated with two to three times greater preva-
lence of coronary heart disease, other heart diseases,
diabetes mellitus, and arthritis. Similarly, a significant
association was identified between exhaustion and
depression.
CONCLUSION: Prefrailty is common in the youngest
old. The most prevalent frailty criterion is weakness,
which is associated with cardiovascular diseases. Longitu-
dinal studies of the evolution of prefrailty should explore
the role of potential interactions between individual frailty
criteria and specific chronic diseases. J Am Geriatr Soc
60:1687–1694, 2012.
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The concept of frailty has been developed in geriatricsduring past decades1 to define a state of vulnerability
and loss of adaptation to stress.2–4 Different models1 have
been used to explain the development of frailty. Fried and
colleagues, considering frailty as a biological syndrome,
suggested the occurrence of a pathophysiological “cycle of
frailty associated with declining energetics and reserve”2
and proposed an operational definition for a frailty pheno-
type that relies on five criteria: slowness, weakness, weight
loss, low level of physical activity, and self-reported
exhaustion.2 Individuals with at least three of the five
criteria are classified as frail, and those fulfilling one or
two criteria are considered prefrail or intermediate. The
frailty phenotype independently predicts recurrent falls,5
disability,2,6,7 hip fracture,5,6 hospitalization,2 nursing
home admission,7 and death.2,5–9
Nevertheless, many gaps remain in the understanding
of the physiopathology of frailty. Although the risk of
adverse outcomes seems to increase gradually from the
state of nonfrailty to prefrailty and frailty,2 little is known
about the significance of prefrailty. This intermediate stage
may provide insights into the mechanisms involved. The
stage of prefrailty also deserves special interest because
frailty is a continuous process that may be partly revers-
ible, especially in its initial phases.10
Whereas the association between cardiovascular dis-
ease and frailty has been demonstrated,11,12 the current
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study aimed to identify which frailty criteria were more
specifically linked with cardiovascular disease. Likewise,
although the association between other chronic diseases
(e.g., arthritis, diabetes mellitus, chronic obstructive pul-
monary disease) and frailty has been established,2,13–15 it
was hypothesized that specific chronic diseases might be
more tightly linked with one or another frailty criterion.
These associations might be involved in different parts of
the frailty cycle and could provide indications regarding
the physiopathology of frailty.
In this report, it was hypothesized that prefrailty would
not be rare in the community-dwelling population aged 65
to 70; the prevalence of chronic diseases and disability
would differ significantly between prefrail and nonfrail pop-
ulations; and the distribution of chronic diseases and disabil-
ity would differ between individuals with different frailty
criteria, even among prefrail individuals experiencing a sin-
gle frailty criterion. To test these hypotheses, the data from
the population-based Lausanne cohort Lc65+were analyzed.16
METHODS
Design
The Lausanne cohort Lc65+ is a longitudinal, observational
study started in 2004 at the University of Lausanne Hospital
Center (Switzerland).16 It aims to investigate the determi-
nants, manifestations, and outcomes of frailty from its earli-
est stage in the general population. A sample of 1,564
individuals representative of the general community-dwell-
ing population has been enrolled and is currently being fol-
lowed from age 65 to death. The ethics committee of the
Faculty of Biology and Medicine of the University of Lau-
sanne has approved the study protocol.
Recruitment Process and Inclusion Criteria
Individuals were enrolled at the age of 65 to 70 and pro-
vided written informed consent to participate.16 To be
included in 2004, participants had to be residents of
Lausanne (city of 125,000 inhabitants) born between 1934
and 1938. Exclusion criteria at enrollment were being insti-
tutionalized or unable to respond because of advanced
dementia. Enrollment has been previously described.16 Of
the 3,056 people who were initially mailed questionnaires,
2,096 (69%) replied, of whom 1,564 (75%) agreed to par-
ticipate.16 Overall, nonparticipants had demographic char-
acteristics similar to those of participants;16 only 8% of
those refusing to participate attributed their refusal to poor
health,16 and 58% had “a general reluctance to participate
in any survey.” Of the 1,564 respondents to the initial ques-
tionnaire, 1,524 (97.4%) were still eligible,16 and 1,422
(93.3%) participated in the baseline assessment in 2005.
The present analysis, which focused on prefrailty,
included all participants with complete data for frailty
classification (nonfrail, prefrail, or frail; n = 1,283).
Assessment Process
Baseline data were collected in 2004 using a self-adminis-
tered questionnaire sent to participants’ homes, followed by
an interview at the study center with measurements and per-
formance tests conducted by trained medical assistants in
2005. The questionnaire included items used in the Swiss
health surveys, Monitoring of Trends and Determinants in
Cardiovascular Disease17 and the Survey of Health, Aging
and Retirement in Europe (SHARE).18 Items on self-
reported medical diagnoses of diseases (“Has a doctor ever
told you that you had…?”) assessed coronary heart disease
(CHD), other heart diseases, stroke, diabetes mellitus,
hypertension, chronic respiratory disease, osteoporosis,
arthritis, cancer, gastrointestinal ulcer, depression, and
hypercholesterolemia. In accordance with the lists of medi-
cal diagnoses used in SHARE19,20 and the Cardiovascular
Health Study (CHS),2 only eight of these diagnoses were
included in the variable “number of chronic diseases”:
CHD, other heart diseases, stroke, diabetes mellitus, hyper-
tension, chronic respiratory disease, arthritis, and cancer.
Disability in basic or instrumental activities of daily
living (ADLs or IADLs) was assessed according to two
questions: “During the last four weeks, did you have diffi-
culty with performing the following activities: taking a
shower or a bath, getting dressed, eating, getting in/out of
bed or an arm-chair, using the toilets?” (ADLs), and “Dur-
ing the last four weeks, did you have difficulty shopping
or performing your usual tasks at home?” (IADLs). There
were three possible answers: No, I have had no difficulty
at all; I have had difficulties with one or more of these
activities, but I didn’t get help; and I have received help
with one or more of these activities. Participants who had
received help were considered to have disability.
Frailty Assessment
The clinical assessment was conducted following a stan-
dardized protocol.16 Frailty was assessed at baseline
according to the five dimensions of the phenotype
described by Fried,2 although these dimensions were
operationalized with partly different criteria; Table 1,
reproduced from a previous publication about Lc65+,16
details how frailty characteristics were measured in CHS2
and in Lc65+. Participants with three to five frailty criteria
in Lc65+ were categorized as frail, and those with one or
two criteria were categorized as prefrail.
Statistical Analysis
Statistical analyses were performed using Stata 12 software
(Stata Corp, College Station, TX). Results were expressed
as absolute numbers and percentages. Bivariate compari-
sons were performed using the chi-square test or Fisher
exact test for categorical variables. Multivariate odds
ratios (ORs) and 95% confidence intervals (CIs) of the
prevalence of self-reported chronic diseases were calculated
in participants with zero or one frailty criterion using
multivariate logistic regression analysis adjusted for sex
and all five frailty criteria.
RESULTS
Characteristics of the Sample
The study sample initially included all participants who
participated at baseline in the Lc65+ cohort in 2004/05
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and were evaluated for frailty (n = 1,283). Birth years
were evenly distributed throughout the 1934–1938 per-
iod, and 58.5% of participants were women, closely
reflecting proportions observed in this age range in the
community-dwelling population of Lausanne. Of the
1,283 participants, 71.1% were classified as nonfrail,
26.4% as prefrail, and 2.5% as frail (Table 2). No par-
ticipant had all five criteria of the frailty phenotype.
Weakness was the most frequent criterion and was expe-
rienced by 14.3% of Lc65+ participants (n = 183), fol-
lowed by weight loss (n = 115, 9.0%), low activity
(n = 88, 6.9%), exhaustion (n = 81, 6.3%), and slowness
(n = 43, 3.4%). One-third (34.9%) reported two or
more chronic conditions diagnosed by a physician, and
37.5% reported a single chronic condition. Hyperten-
sion, hypercholesterolemia, and arthritis were most often
reported. Most participants were independent in their
daily life; 3.7% had received help during the four previ-
ous weeks for IADLs only and an additional 1.6% for
ADLs.
Most prefrail participants also had at least one
chronic disease; 27.5% of all participants had none of the
eight listed chronic diseases: 32.0% of the nonfrail, 17.2%
of the prefrail, and 9.4% of the frail (test for trend
P < .001, Table 2). Of the 1,282 participants with com-
plete data regarding the three health dimensions, 288
(22.5%) had no frailty criterion, no disability, and no
chronic disease. Of the 338 prefrail participants with com-
plete data, 57 (16.9%) had no disability and no chronic
disease.
Characteristics of Prefrail Individuals
Prefrail participants differed significantly from nonfrail
participants in many respects (Table 2). Prefrail partici-
pants were more frequently female and were older. Fewer
than 2% of nonfrail participants needed help in IADLs
(1.4%) and ADLs (0.2%), more than 10% of prefrail
participants did so (IADL, 7.4%; ADLs, 2.9%; P < .001).
Prefrail individuals also reported comorbidity ( 2 chronic
diseases) more often. Specific health conditions that were
more frequently reported in prefrail participants than in
nonfrail participants included CHD (P = .04), other heart
diseases (P < .001), stroke (P = .01), diabetes mellitus
(P < .001), hypertension (P < .001), chronic respiratory
diseases (P = .02), osteoporosis (P = .01), arthritis
(P < .001), and depression (P < .001).
The proportion of women increased across the three
frailty categories (nonfrail, 56.5%; prefrail, 62.8%; frail,
71.9%; test for trend P = .01), as did the proportion of
older participants (born in 1934: nonfrail, 16.9%; prefrail,
23.9%; frail, 28.1%; test for trend P < .001).
Across frailty categories, there were increasing trends in
the prevalence of disability (test for trend P < .001), comor-
bidity (test for trend P < .001), CHD (test for trend
P < .001), other heart diseases (test for trend P < .001),
stroke (test for trend P < .001), diabetes mellitus (test for
trend P < .001), hypertension (test for trend P < .001),
chronic respiratory disease (test for trend P = .001), osteo-
porosis (test for trend P = .006), arthritis (test for trend
P < .001), and depression (test for trend P < .001; Table 2).
Table 1. Operationalization of Frailty Characteristics in the Cardiovascular Health Study (CHS)2 and the Lau-
sanne cohort Lc65+ Study, Reproduced from Santos-Eggimann et al.16
Frailty
Criteria
Cardiovascular Health Study Lausanne Cohort Lc65+ Study
Characteristic
Shrinking Unintentional weight loss > 10 pounds in prior year Any reported unintentional weight loss in prior year
Weakness Grip strength: lowest 20% (according to sex and body mass
index)
Grip strength: application of CHS sex- and body mass index–
specific cutoff valuesa
Poor
endurance,
exhaustion
Exhaustion self-report (CES-D Depression Scale): responds “a
moderate amount of the time (3–4 days) or most of the time”
to either statement “I felt that everything I did was an effort”
or “I could not get going” in the last week.
Exhaustion self-report: responds “much” to the question: “Did
you have feelings of generalized weakness, weariness, lack of
energy in the last four weeks?”
Slowness Walking time/15 feet: slowest 20% (by gender, height) Walking time/20 m: application of CHS gender- and height-
specific cutoff values
Low activity Physical activity self-report: lowest 20% kcal/week expenditure,
according to sex, estimated from the short version of the
Minnesota Leisure Time Activity questionnaire
Physical activity self-report: (i) doing <20 minutes of sports
per week, (ii) walking <90 minutes per week, and (iii)
avoidance of climbing stairs or carrying light loads in daily
activitiesb
Classification
Nonfrail or
robust
0 criterion present 0 criterion present
Intermediate,
possibly
prefrail
1–2 criteria present 1–2 criteria present
Frail 3–5 criteria present 3–5 criteria present
a The grip strength test was performed on the right hand46 (using the best of three measurements).
b Low activity was defined when all three statements were fulfilled. This measurement of physical activity based on three questions has been adapted
from the Monitoring of Trends and Determinants in Cardiovascular Disease Physical Activity Questionnaire17,47 to suit activity patterns of individuals
aged 65–70.
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Characteristics of Prefrail Individuals Fulfilling a Single
Criterion
When considering the 252 participants with a single frailty
criterion, 102 (40.5%) had weakness, 73 (29.0%) had
weight loss, 43 (17.1%) had low activity, 29 (11.5%) had
exhaustion, and five (2.0%) had slowness. The 102 per-
sons with weakness as the sole frailty criterion differed sig-
nificantly from nonfrail participants: 66.7% were women
(vs 56.5% of nonfrail participants, chi-square P = .048),
and they were older than nonfrail participants (P = .01).
Individuals experiencing weakness alone needed help with
ADLs and IADLs more frequently (6% for IADLs only,
4% for ADLs, P < .001, Table 3). They more frequently
reported two or more chronic diseases (P < .001). Weak-
ness was significantly associated with CHD (P = .003),
other heart diseases (P = .001), diabetes mellitus (P = .04),
and arthritis (P = .001). Multivariate logistic regression
analysis (adjusted for sex and all five frailty criteria, results
not shown in Table 3, but available upon request) indi-
cated that low grip strength was associated with two to
three times greater prevalence of CHD (multivariate
OR = 2.9, 95% CI = 1.6–5.3), other heart diseases (multi-
variate OR = 2.9, 95% CI = 1.5–5.6), diabetes mellitus
(multivariate OR = 2.2, 95% CI = 1.2–4.1), and arthritis
(multivariate OR = 1.9, 95% CI = 1.2–2.8). The 29
participants with exhaustion as the single frailty criterion
reported depression (P = .01) and receiving help with
ADLs and IADLs (P = .04) significantly more often than
nonfrail participants (multivariate OR for the prevalence
of depression = 3.0, 95% CI = 1.3–7.0).
DISCUSSION
In this cross-sectional analysis of the Lc65+ cohort study
at baseline, 26% of all participants were prefrail, and 2%
were frail. Prefrail individuals had significantly more com-
orbidity and ADL and IADL disability than nonfrail par-
ticipants. Weakness was the most frequent frailty criterion,
and when present in isolation, it was associated with two
to three times greater prevalence of CHD, other heart
diseases, diabetes mellitus, and arthritis. Similarly, a
Table 2. Demographic and Health Characteristics at Baseline (2004/5) in Nonfrail, Prefrail (1 or 2 Frailty Crite-
ria), and Frail (3–5 Criteria) Participants
Characteristic
Nonfrail,
n = 912 n (%)
Prefrail,
n = 339
Frail,
n = 32
Total,
N = 1,283
v2 P-Value (Nonfrail
vs Prefrail)
Test for Trend P-value (Nonfrail,
Prefrail, and Frail)
Female 515 (56.5) 213 (62.8) 23 (71.9) 751 (58.5) .04 .01
Birth year
1938 197 (21.6) 52 (15.3) 3 (9.4) 252 (19.6) .001 <.001
1937 194 (21.3) 51 (15.0) 3 (9.4) 248 (19.3)
1936 178 (19.5) 76 (22.4) 12 (37.5) 266 (20.7)
1935 189 (20.7) 79 (23.3) 5 (15.6) 273 (21.3)
1934 154 (16.9) 81 (23.9) 9 (28.1) 244 (19.0)
Help received with ADLs or IADLs
None 897 (98.4) 304 (89.7) 13 (40.6) 1,214 (94.6) <.001a <.001
With IADLs only 13 (1.4) 25 (7.4) 10 (31.3) 48 (3.7)
With ADLs 2 (0.2) 10 (2.9) 9 (28.1) 21 (1.6)
Number of chronic diseasesb
0 292 (32.0) 58 (17.2) 3 (9.4) 353 (27.5) <.001 <.001
1 359 (39.4) 118 (34.9) 4 (12.5) 481 (37.5)
 2 261 (28.6) 162 (47.9) 25 (78.1) 448 (34.9)
Self-reported medical diagnoses
Coronary heart
disease
72 (7.9) 39 (11.5) 10 (31.3) 121 (9.4) .04 <.001
Other heart
diseasesc
45 (4.9) 41 (12.1) 5 (15.6) 91 (7.1) <.001 <.001
Stroke 11 (1.2) 11 (3.3) 9 (28.1) 31 (2.4) .01 <.001
Diabetes mellitus 71 (7.8) 52 (15.4) 6 (18.8) 129 (10.1) <.001 <.001
Hypertension 334 (36.6) 162 (47.9) 20 (62.5) 516 (40.3) <.001 <.001
Hypercholesterolemia 320 (35.1) 127 (37.6) 14 (43.8) 461 (36.0) .41 .24
Chronic respiratory
disease
62 (6.8) 37 (10.9) 6 (18.8) 105 (8.2) .02 .001
Osteoporosis 90 (9.9) 50 (14.8) 6 (18.8) 146 (11.4) .01 .006
Arthritis 291 (31.9) 154 (45.6) 17 (53.1) 462 (36.0) <.001 <.001
Cancer 104 (11.4) 45 (13.3) 7 (21.9) 156 (12.2) .35 .09
Gastrointestinal ulcer 51 (5.6) 25 (7.4) 4 (12.5) 80 (6.2) .24 .08
Depression 101 (11.1) 63 (18.6) 7 (21.9) 171 (13.3) <.001 <.001
The chi-square (v2) test compares proportions in the group of nonfrail participants with the group of prefrail participants.
a Fisher exact two-tailed test (if expected frequency <5 in any of the cells).
b All chronic diseases were self-reported medical diagnoses. The number of chronic diseases included coronary heart disease, other heart diseases, stroke,
diabetes mellitus, hypertension, chronic respiratory disease, arthritis, and cancer (maximum number = 8).
c Congestive heart failure, cardiac valvular disease, and heart muscle disease.
ADL = activity of daily living; IADL = instrumental activity of daily living.
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significant association was identified between exhaustion
and depression. The existence of associations between indi-
vidual frailty criteria and specific chronic diseases suggests
that they could result from common pathophysiological
changes. Further exploration of these processes in longitu-
dinal studies may contribute to understanding the natural
history of frailty.
Prevalence of Frailty, Disability, and Comorbidity at
Baseline
In this “young old” age group (65–70), frailty was uncom-
mon (2%), whereas one-quarter were prefrail. Any attempt
to compare prevalence estimates across studies should be
conducted with caution, because the definitions of the
frailty criteria, the distribution of confounders (e.g., age
and sex), and exclusion criteria differ between studies.
Prefrailty prevalence in Lc65+ appeared to be lower than
in other studies, which reported a prevalence ranging from
43% to 54%.2,5,21–23 In SHARE, prefrailty prevalence
after age 65 ranged from 35% in Germany to 51% in
Spain, with a north–south gradient,18 but these studies
included older individuals (mean age from 7418,21 to
825,22,23). In the estimation of the authors of the current
study, the prevalence of prefrailty among CHS participants
aged 65 to 74 should have approximated 44%.2 This sam-
ple included older individuals than in Lc65+, as well as a
minority cohort of 687 African American men and women
(who have higher frailty prevalence), and the frailty crite-
ria measured in CHS2 and Lc65+ were different.
In Lc65+, 48% of prefrail and 78% of frail individu-
als reported at least two chronic diseases; corresponding
percentages in CHS were 54% and 68%,2 although CHS
had a somewhat different list of chronic diseases (validated
by clinical tests2) and other exclusion criteria (Parkinson’s
disease; Mini-Mental State Examination score less than 18;
use of carbidopa-levodopa, donepezil, or antidepressants).
In a Taiwanese health survey of elderly adults,15 76% of
prefrail and 85% of frail individuals had two or more self-
reported chronic diseases, although the definition of
chronic disease was broader, including osteoporosis and
cataracts. Disability prevalence (basic or instrumental)
appeared to be lower in Lc65+ prefrail participants (10%)
than in CHS (29%),2 and the prevalence of instrumental
Table 3. Comparison of the Prevalence of Chronic Diseases and Disability in Nonfrail Participants (n = 912) and
in Participants with a Single Frailty Criterion (n = 252)
Variable
Nonfrail,
n = 912 n (%)
Frailty Criterion
Weakness
(Grip), n = 102
Weight Loss,
n = 73
Low Activity,
n = 43
Exhaustion,
n = 29
Slowness (Gait
Speed), n = 5
n (%)
P-
value n (%)
P-
value n (%)
P-
value n (%)
P-
value n (%)
P-
value
Help received with ADLs
and IADLs
<.001a .67a .22a .04a <.001a
None 897 (98.4) 92 (90.2) 73 (100.0) 41 (95.3) 27 (93.1) 3 (60.0)
IADLs only 13 (1.4) 6 (5.9) 0 (0.0) 2 (4.7) 1 (3.4) 0 (0.0)
ADLs 2 (0.2) 4 (3.9) 0 (0.0) 0 (0.0) 1 (3.4) 2 (40.0)
Number of chronic
diseasesb
<.001 .007 .16 .43 .74a
0 292 (32.0) 21 (20.6) 12 (16.7) 10 (23.3) 6 (20.7) 1 (20.0)
1 359 (39.4) 32 (31.4) 29 (40.3) 15 (34.9) 13 (44.8) 3 (60.0)
 2 261 (28.6) 49 (48.0) 31 (43.1) 18 (41.9) 10 (34.5) 1 (20.0)
Self-reported medical diagnoses
Coronary heart disease 72 (7.9) 17 (16.7) .003 5 (6.9) .77 3 (7.0) 1.00a 1 (3.4) .72a 0 (0.0) 1.00a
Other heart diseases c 45 (4.9) 13 (12.7) .001 7 (9.7) .10a 5 (11.6) .07a 2 (6.9) .65a 1 (20.0) .23a
Stroke 11 (1.2) 2 (2.0) .38a 0 (0.0) 1.00a 2 (4.7) .11a 1 (3.4) .32a 0 (0.0) 1.00a
Diabetes mellitus 71 (7.8) 14 (13.7) .040 10 (13.9) .07 7 (16.3) .08a 2 (6.9) 1.00a 1 (20.0) .34a
Hypertension 334 (36.6) 43 (42.2) .27 34 (47.2) .07 19 (44.2) .32 11 (37.9) .89 3 (60.0) .36a
Hypercholesterolemia 320 (35.1) 37 (36.3) .81 30 (41.7) .26 16 (37.2) .78 13 (44.8) .28 1 (20.0) .66a
Chronic respiratory
disease
62 (6.8) 9 (8.8) .45 8 (11.1) .17 3 (7.0) 1.00a 4 (13.8) .14a 1 (20.0) .30a
Osteoporosis 90 (9.9) 12 (11.8) .55 10 (13.9) .28 4 (9.3) 1.00a 4 (13.8) .52a 3 (60.0) .009a
Arthritis 291 (31.9) 49 (48.0) .001 28 (38.9) .22 13 (30.2) .82 14 (48.3) .06 1 (20.0) 1.00a
Cancer 104 (11.4) 6 (5.9) .09 12 (16.7) .18 8 (18.6) .15 2 (6.9) .76a 0 (0.0) 1.00a
Gastrointestinal ulcer 51 (5.6) 9 (8.8) .19 6 (8.3) .30a 3 (7.0) .73a 0 (0.0) .40a 1 (20.0) .25a
Depression 101 (11.1) 16 (15.7) .17 10 (13.9) .47 6 (14.0) .62a 8 (27.6) .013a 1 (20.0) .45a
P-values are from the chi-square test for comparison of proportions with nonfrail participants.
a Fisher exact two-tailed test (if expected frequency <5 in any of the cells).
b All chronic diseases are self-reported medical diagnoses. The number of chronic diseases included coronary heart disease, other heart diseases, stroke, dia-
betes mellitus, hypertension, chronic respiratory disease, arthritis, and cancer (maximum number = 8).
c Congestive heart failure, cardiac valvular disease, and heart muscle disease.
ADL = activity of daily living; IADL = instrumental activity of daily living.
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disability in Lc65+ (7%) seemed to be lower than in the
Osteoporotic Fractures in Men Study8 (MrOS, 20%) or
the MOBILIZE Boston Study24 (28%), although disability
was defined more strictly in Lc65+ (having received help
with ADLs in the past 4 weeks) than in CHS2 or MOBI-
LIZE24 (difficulty in 1 ADLs). CHS2 and MOBILIZE24
also included older participants. Increasing trends in the
prevalence of comorbidity and disability across frailty cate-
gories confirm previous results.2,15
The Most Frequent Frailty Criterion in Prefrail
Participants
In Lc65+, the most frequent frailty criterion (alone and in
association with other criteria) was weakness, followed by
shrinking, low activity, exhaustion, and slowness. Weak-
ness prevalence appeared lower in Lc65+ (14%) than in
the 10 countries of SHARE (26%) but similar to Switzer-
land alone (17%).18 Despite the younger age of Lc65+
participants, weakness prevalence seemed slightly higher in
Lc65+ participants than in the men of MrOS (13%),8 pos-
sibly because weakness is more frequent in women25 (a
finding also observed in Lc65+). Shrinking seemed slightly
more prevalent in Lc65+ (any unintentional weight loss
over the past year, 9%) than in MOBILIZE (7%)24 or the
Hertfordshire Cohort Study (4–5%),25 but these studies
defined shrinking as a weight loss of more than 10 pounds
during the past year. The prevalence of exhaustion (deter-
mined with slightly different sentences) appeared to be
similar in Lc65+ (6%), MOBILIZE (9%),24 the Hertford-
shire Cohort Study (6% in men, 10% in women),25 and
MrOS (8%).8 Slowness was present in 3% of Lc65+ par-
ticipants, 3% of MrOS participants,8 and 8% of the par-
ticipants in a German study on prefrail individuals26 that
included institutionalized participants and had differing
exclusion criteria.
Although several articles have identified the most fre-
quent criterion in specific age groups,2,8,18,24,26 to the
knowledge of the authors of the current study, not many
studies have identified the first frailty criterion. In the
Women’s Health and Aging Study II (WHAS II),27 a longi-
tudinal study with a 7.5-year follow-up period that included
420 nonfrail women aged 70 to 79 at baseline, weakness
was the most common initial manifestation. Although
weakness had the highest prevalence in Lc65+, the cross-
sectional design of the present report precludes the conclu-
sion that it is the first criterion to appear. This hypothesis
must be evaluated in the follow-up data. Grip strength has
already been identified as a powerful independent predictor
of disability28 and of cause-specific and total mortality.29
The Chronic Diseases Most Frequently Associated with
Prefrailty in Lc65+
Prefrail Lc65+ participants had a significantly higher
prevalence of CHD, other heart diseases, stroke, diabetes
mellitus, hypertension, chronic respiratory disease, osteo-
porosis, arthritis, and depression than nonfrail individuals,
findings also observed in CHS2 and WHAS II.27 As in
CHS2 and WHAS II,27 prefrail participants had a
significantly higher prevalence of disability than nonfrail
participants.
Previous studies have reported associations between
chronic diseases2,12,26,27,30 and prefrailty but not with indi-
vidual frailty criteria. In Lc65+, low grip strength was
associated with a significantly greater prevalence of CHD,
other heart diseases, diabetes mellitus, and arthritis. The
link between frailty and mortality has often been described
as being mediated through the cardiovascular system (sub-
clinical disease).12 Of the pathways suggested to explain
this association, atherosclerosis, a state of chronic inflam-
mation resulting in a loss of lean mass (among other con-
sequences), has been proposed.12 The association between
low grip strength and cardiovascular diseases observed in
Lc65+ is consistent with this hypothesis. In addition, the
association between diabetes mellitus and low grip
strength has long been reported,31 and individuals with
diabetes mellitus develop the conditions necessary for
frailty earlier than other individuals as they age.13
Exhaustion as a single frailty criterion was signifi-
cantly associated with depression, an association previ-
ously observed.26 A Taiwanese survey also reported a high
prevalence of depressive symptoms in frail (89%) and pre-
frail (32%) elderly adults.15 In Lc65+, 19% of prefrail
participants reported depression (vs 11% of nonfrail par-
ticipants, P < .001). Although the cause of its association
with frailty remains unknown, depression has a recognized
prognostic value.32
These cross-sectional associations between individual
frailty criteria and distinct chronic diseases deserve addi-
tional study in longitudinal analyses. Arthritis may be a
local and straightforward explanation for weakness, and
this frailty criterion may not be specific. The independent
prognostic significance of weakness as a sole frailty crite-
rion should be evaluated before weakness alone can be
considered a target for prevention.
Limitations
Of all 3,056 individuals contacted, 1,422 (47%) completed
the baseline assessment. This final participation rate was
comparable with other surveys involving community-
dwelling individuals (rather than hospitalized persons) in
Western countries;33–35 for example, in CHS,33 31% of
those contacted in the randomly selected sample were
enrolled. Studies looking for systematic differences in
health status between participants and nonparticipants
yielded inconsistent results.34,36–38 The nonparticipation
rate seems to be higher in lower socioeconomic groups.38
There might have been a selection bias due to differential
participation rates across frailty categories in Lc65+,
although only 8% of those refusing to participate attrib-
uted their refusal to poor health.16 The prevalence of
frailty, comorbidity, and disability may have been underes-
timated if affected individuals had lower participation
rates than healthy persons, which could affect the general-
izability of the findings.
Although Lc65+ frailty criteria differed partly from
the criteria that Fried and colleagues proposed,2 different
operationalizations of the phenotype’s dimensions reflect
the same underlying mechanisms (e.g., weight loss, sarco-
penia, and diminution of the reserve capacity). The consis-
tency of observations across diverse studies with various
measurement instruments supports the plausibility of the
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findings. These limitations (e.g., potential selection bias
and different definitions of frailty criteria) might have
affected prevalence estimates for prefrailty but are unlikely
to explain the existence of associations between individual
frailty criteria and specific chronic diseases. Weakness was
involved in most of the associations observed in Lc65+,
and it was measured using Fried’s exact definition.
Assessment of comorbidity was based on self-reporting
of medical diagnoses. Self-reported diseases are often
used in population-based studies15,19,20 and seem to be
accurate39–41 for specific diagnoses. Studies have observed
substantial41–43 agreement between self-reporting and med-
ical reporting of medical conditions, particularly for life-
threatening, acute-onset diseases (e.g., myocardial infarc-
tion and stroke) and chronic symptomatic disorders requir-
ing ongoing management (e.g., diabetes mellitus).39,44,45
Participants usually underreport hypertension,45 and agree-
ment on heart failure differs between studies.40,43 When
compared with general practitioners’ information, the
accuracy of patient self-reporting is substantial for cancer
but poor for arthritis.39 Nonetheless, errors in disease
measurement due to self-reporting are unlikely to have a
differential distribution across frailty categories; un-
derreporting of some conditions should have led to nondif-
ferential misclassification, attenuating the strength of
associations between isolated frailty criteria and specific
diseases.
Strengths
Unlike other studies,2,21–23 this study population had a
narrow age range (65–70), which limits the potential for
age-related confounders or biases, such as selection bias
due to differential participation rates across age groups.33
Except for institutionalization and advanced dementia,
this study did not exclude individuals with specific dis-
eases, whereas other studies excluded persons with termi-
nal cancer,15 arthritis, angina pectoris, chronic obstructive
pulmonary disease, or depression26 or those taking an-
tidepressants.2 The design of the current study allowed
associations between individual frailty criteria and chronic
diseases to be examined. Furthermore, the limited number
of exclusion criteria led to a study sample that was more
representative of the source population.
CONCLUSION
Frailty is rare in the youngest old, whereas prefrailty is
common. Weakness is the most frequent frailty criterion;
when present in isolation, it is significantly associated with
CHD, other heart diseases, diabetes mellitus, and arthritis.
Likewise, exhaustion is associated with depression. Longi-
tudinal studies regarding the evolution of prefrail persons
should explore the role of potential interactions between
individual frailty criteria and specific chronic diseases.
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